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402a Tuesday, February 5, 2013positive allosteric modulators by interacting with the Ca2þ binding site. In ad-
dition, extracellular Ca2þ differentially reduces the inhibition of the receptor by
antagonists and negative allosteric modulators. Our studies open a new avenue
for modulating drug effects and developing novel drugs against neurodegener-
ative diseases.
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Experimental investigations of ligand-activated receptors are often based on
binding measurements that detect the total fraction of occupied binding sites
at various ligand concentrations. We use calmodulin, an important calcium sen-
sor protein, as a test system to document the uncertainties in model parameters
estimated by fitting various models to total binding data. Using nonlinear
least-squaresmethods, we obtain excellent fits (<1%RMSerror) to synthetic to-
tal binding data with the same characteristics as the published binding data using
parameter sets with binding affinities varying by over four orders of magnitude
for each site. This result identifies a significant obstacle blocking progress to-
ward the goal of developing accurate, quantitativemodels of receptor activation.
The use of noiseless data in our analysis suggests that the large uncertainties in
the estimated parameters are not a problem of data quality, but rather reflect an
intrinsic limitation of total binding data. Using analytical matrix algebra tech-
niques and numerical simulations, we discover a fundamental relationship be-
tween the mathematical structure of the equations describing various types of
binding data and the number and type of parameters that may be determined
accurately from regression analysis of that data. Ideas based on Boolean logical
principles are used to design a new type of binding experiment that significantly
improves upon total binding data in its power to constrain physically realistic
models of receptor activation. These experiments, which we call conditional
binding, report on the simultaneous occupancies of two different receptor bind-
ing sites. Our approach is general and the conclusions are applicable to the many
macromolecular systems that are activated or modulated by ligand binding.
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Fructuose bisphostate aldolase (FBA) and triosephosphate isomerase (TIM) are
the fourth and fifth enzymes in the glycolysis pathway and they are known to
bind. FBA cleaves the six-carbon fructose 1, 6-bisphosphate into two three-
carbon components – dihydroxyacetone phosphate (DHAP) and glyceralde-
hyde 3-phosphate (GAP). TIM converts DHAP into GAP, a substrate for the
subsequent synthetic step. These two alpha/beta barrel proteins have high struc-
tural similarity – with a core RMSD 4.8A˚. These two enzymes have low activ-
ity in the monomeric form with the functionally active structures present in
higher oligomeric states. By applying Elastic Network Model, we find the
modes of motions that are functionally important for these proteins. We build
models for the complex between these two proteins to investigate their impor-
tant motions in their complexes as well as for their different oligomeric states
including those that are different in different species to learn their important
modes of motions for different functionalities. For each protein, by multiple se-
quence alignment across the species, we predict the coevolving residues and
cluster these residues along the structure. We build the information transfer
pathways from the important interface residues to the catalytic residues.
Change in these pathways in different oligomeric states maybe be related to
the change of motions in the catalytic region in different oligomeric states.
We use this knowledge about the changes in motions and the information trans-
fer pathways within the structure of these interacting proteins as constraints for
selecting the computational docked models of complexes between these two
proteins to preserve their functional motions.
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For several transcription factors, the same ligand can act as a positive and neg-
ative allosteric effector in a context dependent manner. The structural and
molecular bases of such effects are unknown. Here it is shown that modulation
of conformational fluctuations within allosteric systems can be used as a mech-anism to tune protein ensembles such that a given ligand can act as both a pos-
itive and negative allosteric effector. Importantly, this mechanism can be
robustly encoded in the ensemble, and does not require that the interactions be-
tween the ligand and the protein differ when it is acting either as a positive or
negative effector. Instead, the effect is due to the relative probabilities of states
prior to the addition of the ligand and is encoded in the thermodynamic cou-
pling architectures between protein domains. The ensemble view of allostery
that is illuminated by these studies suggests that rather than being seen as
switches with fixed responses to allosteric activation, ensembles can evolve
to be ‘‘functionally pluripotent’’, with the capacity to up or down regulate ac-
tivity in response to a stimulus. This result not only helps to explain the prev-
alence of intrinsic disorder in transcription factors and other cell signaling
proteins, it provides important insights about the energetic ground rules govern-
ing site-to-site communication in all allosteric systems.
Relevant citation
Motlagh HN, Hilser VJ: Agonism/antagonism switching in allosteric ensem-
bles. Proceedings of the National Academy of Sciences of the United States of
America (2012) 109(11):4134-4139.
2067-Pos Board B86
Allosteric Modulation of WT and H1047R Mutant PI3Ka Investigated by
MD Simulations
Paraskevi Gkeka, Thomas Evangelidis, Zoe Cournia.
Biomedical Research Foundation, Academy of Athens, Athens, Greece.
Kinases are one of the most intensively pursued drug targets investigated for
the treatment of cancer. Kinase inhibitors usually target the ATP binding
site; however, the similarity of this site across many kinases often results to
non-selectivity. Therefore, allosteric modulation of kinases is of paramount im-
portance as it may result in increased selectivity; many highly selective inhib-
itors have been reported to inhibit kinases by allosteric mechanisms. PI3Ka is
the most frequently mutated kinase in human cancers with one of its most com-
mon mutations being a histidine changed to arginine in exon 20 (H1047R).
PIK-108, a known PI3Ka inhibitor, was recently found to occupy an allosteric
binding pocket in the wild type (WT) murine protein, close to the H1047R mu-
tation. In order to assess the interactions, stability and allosteric effects of the
inhibitor on PI3Ka, MD simulations in aqueous solution were performed for
130ns for the WT human, WT murine, and H1047R human mutant proteins
with PIK-108 placed in both catalytic and allosteric sites. Interestingly, PIK-
108 remained stable in both sites in all three variants. While in both the WT
human and murine forms, the same ligand:protein interaction motifs are ob-
served in the allosteric and catalytic pockets, these interactions are markedly
different in the mutant form. In the mutant form, the allosteric pocket opens
up and forms an altered hydrogen bond network with the ligand compared to
theWT. Additionally, in the catalytic pocket, significant differences are evident
in the interaction network formed between the inhibitor, P-loop, and the activa-
tion loop between the two protein forms. Overall, the ligand:protein interaction
differences between the mutant andWT PI3Ka proteins observed in the present
study provide a rich basis for the design of mutant-specific PI3Ka inhibitors.
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Calcium sensing receptor (CaSR), along other members of the family C G
protein-coupled receptors (GPCRs), play very important roles in responding
to changes in the extracellular calcium concentrations and in circulating levels
of amino acids and integrating these extracellular signals into alterations in in-
tracellular signaling pathways. However, detailed structure properties of the
CaSR which are necessary to characterize the mechanism of its physiological
function are still unrevealed. We have reported several potential calcium-
binding sites located within the CaSR’s extracellular domain using our
developed computational algorithms. In the present study, we first report the
differential effects of several disease-related mutations located at the predicted
calcium binding sites on the inhibition and activation of intracellular calcium
responses using single cell imaging. Mutating to different residues at two lo-
cations near the hinge region of the ECD could lead to either significantly
lose of function of the receptor or gain of function (switch function mutations).
Amino acid binding results in differential rescue effect in altering intracellular
calcium responses, especially calcium oscillations.We have further probe the
effect of mutation and amino acid binding on the correlation motion, cooper-
ativity, and synergistic activation using mammalian expressed and purified
Tuesday, February 5, 2013 403aextracellular domain (ECD) of CaSR with various spectroscopic methods in-
cluding the tryptophan fluorescence titration, circular dichroism (CD) and nu-
clear magnetic resonance (NMR) as well as molecular dynamic simulation.
These results provide important implications for our understanding of how
the CaSR integrates information about these two completely different classes
of agonists–an inorganic divalent cation, and another hand, a nutrient– how the
receptor senses these agonists in healthy and diseased states.
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Combretastatins, which are an important group of anticancer drugs,were iso-
lated by Pettit et al. from the African tree Combretum caffrum in 1989. Addi-
tionally, Liang et al. have reported that ten coumestans were isolated fromthe
roots of Hedysarum multijugum, which is a plant in Hedysarum Linn. of the
family Leguminosae used as a folk herbal drug in northwest China. Coumestans
comprise a class of naturally occurring products with a variety of biological ac-
tivities including phytoestrogenic, antibacterial, antifungal, antimyotoxic, and
phytoalexine effects. The anticancer properties of demethylwedelolactone
(DWEL) and wedelolactone (WEL), which are naturally occurring coumestans,
have not been well characterized. Due to their biological activities, the synthe-
sis of DWEL is achieved in which the longest linear sequence is only eight
steps in 38% overall yield from commercially available phloroglucinol. Furth-
more, the molecular model was examined the interactions of proteins and li-
gands as well. Finally, in this study, we investigated the anti-invasive effects
of synthetic WEL and DWEL on human MDA-MB-231 breast cancer cells.
We found that WEL and DWEL inhibited the anchorage-independent growth
and also suppressed cell motility and cell invasion of MDA-MB-231 cells. In
addition, WEL and DWEL reduced the activity and expression of matrix metal-
loproteinases (MMPs) involved in blocking the IkB-a/NFkB and MEK/ERK
signaling pathways in MDA-MB-231 cells. Furthermore, DWEL suppressed
the metastasis and lung colonization of the tumor cells in the nude mice. Alto-
gether, these data suggest that DWEL derivatives exert anti-invasive growth ef-
fect on breast cancer cells.
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Histone methyltransferases are enzymes that modify histone proteins via meth-
ylation of lysine or arginine residues. These epigenetic modifiers, such as
DOT1L and EZH2, have been found to play important roles in leukemogenic
processes.
Crystallographic and docking methods studied interactions within the DOT1L
binding site. Crystal structures of DOT1L also demonstrated variance in the
binding mode of ligands, possibly due to rearrangement in the DOT1L binding
site. We investigated this possibility by molecular dynamics (MD) simulations
and confirmed significant rearrangement of the substrate binding and activation
loops of DOT1L upon binding to competitive inhibitors. The druggability and
volume fluctuations of the binding pocket over time were determined.
The EZH2 methyltransferase is of interest due to its aberrant activity in many
cancers. Because there is no published crystal structure of EZH2, we used ho-
mology modeling with homologous proteins as templates. This model provides
structural information regarding the binding
modes of the S-adenosyl methionine (SAM)
cofactor and potential inhibitors of EZH2.
Through the synergistic combination of
in silico drug design, organic synthesis
and biochemical assays, our modeling ef-
forts for DOT1L and EZH2 will guide the
chemical syntheses of potent and selective
inhibitors of these enzymes.2071-Pos Board B90
T Cell Receptor Specificity, Cross-Reactivity, and MHC Restriction are
Inextricably Linked and Result from Cooperative Engagement of the
Composite Peptide/MHC Surface
Brian M. Baker, Kurt H. Piepenbrink, Sydney J. Blevins.
University of Notre Dame, Notre Dame, IN, USA.
T cell receptors (TCRs) recognize peptides bound and presented by major his-
tocompatibility complex (MHC) proteins using multiple complementarity de-
termining region (CDR) loops. While numerous analyses have illuminatedstructural and biophysical aspects of TCR recognition, how the distribution
of binding free energy within TCR-pMHC interfaces promotes unique TCR
recognition features, including MHC restriction and the apparent dichotomy
of specificity and cross-reactivity, remains unclear. Utilizing double mutant cy-
cles, here we performed a comprehensive structural and thermodynamic decon-
struction of the interaction between the A6 TCR and the Tax peptide presented
by the class I MHC HLA-A2. In contrast with general expectations, we ob-
served that the central regions of the peptide and its interactions with the hyper-
variable CDR3 loops contribute little to specificity, instead promoting by
dynamic effects the cross-reactivity that is a hallmark of TCR recognition.
We also observed that TCR restriction towards HLA-A2 results from not
from conserved interactions with the germline loops, but instead from strong
interactions with the hypervariable CDR3 loop of the a chain. Formation of
these latter interactions, however, is dependent upon the unique structural prop-
erties of the peptide, highlighting that TCR specificity towards peptide and
MHC can emerge from the need to engage a unique, composite peptide/
MHC interface with tightly coupled structural properties.
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Multidrug (MD) (or xenobiotic) e,ux actively removes cytotoxic chemicals
from the interiors of normal-functioning cells. However, high levels of
e,ux can render drug-targeted cells resistant to a broad-range of therapeutic
agents, including those to which cells were never exposed. Key multidrug
resistance (MDR) contributors include allosteric e,ux pumps, gene regulators
and other sensory systems that mediate the detection and extrusion of diverse
drugs from cellular environments. To date, MDR functions remain only par-
tially understood. Ligand-dependent allosteric control in BmrR has been quan-
titatively addressed using in vitro transcription experiments, dose-response
curves and thermodynamic models that relate the observed transcriptional
responses to ligand binding and changes in BmrR conformation. Preliminary
results indicate that allosteric control in BmrR is sensitive to both energetic
and structural aspects of ligand recognition. Importantly, increased coopera-
tivity in signal control relative to recognition implicates a major allosteric
role for the RNA polymerase.
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Dihydropteroate synthase (DHPS) is an essential enzyme in the bacterial folate
biosynthetic pathway. It catalyzes the condensation of 6-hydroxymethyl-7,8-
dihydropterin pyrophosphate (DHPP) with p-aminobenzoic acid (pABA) to
form the folate intermediate, 7,8-dihydropteroate. DHPS is the target of the
sulfonamide class of antibiotics. Widespread resistance to sulfonamides has de-
creased their clinical use. The active site of DHPS is comprised of three sub-
sites: the structured ‘‘pterin’’ site, the flexible pABA site, and the anion binding
pocket. Most of the drug resistant mutations have been mapped to the pABA
sub-site of DHPS. using an NMR ligand-based screening approach, a number
of structurally unrelated fragment-like small molecules have been identified
that inhibit the enzymatic activity of DHPS from Bacillus anthracis (Ba), Yer-
sinia pestis (Yp), and Staphylococcus aureus (Sa). Fragment hits were shown to
target the three sub-pockets of the active site and a novel site distinct from the
active site. The latter site potentially inhibits via an allosteric mechanism and
has been characterized by high resolution X-ray crystallography.
We screened the Maybridge Fragment library of 1,100 fragments using water
ligand observed gradient spectroscopy (waterLOGSY) as a primary screen
which resulted in a hit rate of 6.7 %. Of the 74 hits, 25 were shown to inhibit
DHPS activity using two independent enzyme activity assays. A total of eight
compounds inhibited the activity of DHPS from three different species (Ba, Yp,
and Sa). In addition to screening for inhibition, the fragment hits were validated
using a number of biophysical techniques including 2D NMR, SPR, competi-
tion waterLOGSY, and X-ray crystallography. Herein, we focus on two frag-
ment hits for which high-resolution x-ray crystal structures are available
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Photoreactive molecules like aryl azides play important role in life sciences,
as practical tools to achieve precisely timed covalent cross-links between li-
gands and targets. Since the azido group is small, stable and biologically inert,
